NVO

Novo Nordisk A/S

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$38.53

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %5.7 / %30

Non-compliant assets / Total market cap %3.4 / %30

Non-compliant income / Total income %3.8 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease.